SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001213900-18-018052
Filing Date
2018-12-31
Accepted
2018-12-31 15:55:54
Documents
3
Group Members
LEES PHARMACEUTICAL INTERNATIONAL LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d1218chinacardi_windtree.htm SC 13D 109592
2 JOINT FILING AGREEMENT, DATED AS OF DECEMBER 28, 2018, BETWEEN CHINA CARDIOVASCU sc13d1218ex7-01china_wind.htm EX-7.01 10010
3 ESCROW AGREEMENT, DATED AS OF DECEMBER 21, 2018 sc13d1218ex7-04china_wind.htm EX-7.04 63498
  Complete submission text file 0001213900-18-018052.txt   185031
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-52027 | Film No.: 181259821
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 1/F, BUILDING 20E, PHASE 3 HONG KONG SCIENCE PARK SHATIN K3 0000000
Business Address 1/F, BUILDING 20E, PHASE 3 HONG KONG SCIENCE PARK SHATIN K3 0000000 852 2314 1282
China Cardiovascular Focus Ltd (Filed by) CIK: 0001761072 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D